4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-001532
Options or other derivatives
- President and CEO acquired 391,177 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Torley Helen · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-02-10 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +266,051 | $19.98 | 2030-02-10 | 266,051 | 266,051 | D |
| 2020-02-10 | Grant or award : show line 2 in the form Restricted Stock Units | +125,126 | $0.00 | 125,126 | 125,126 | D |
Loading xslF345X03/edgar.xml…